BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: La Greca G, Sofia M, Lombardo R, Latteri S, Ricotta A, Puleo S, Russello D. Adjusting CA19-9 values to predict malignancy in obstructive jaundice: Influence of bilirubin and C-reactive protein. World J Gastroenterol 2012; 18(31): 4150-4155 [PMID: 22919247 DOI: 10.3748/wjg.v18.i31.4150]
URL: https://www.wjgnet.com/1007-9327/full/v18/i31/4150.htm
Number Citing Articles
1
Alessandra Fusco, Francesca Baorda, Lorenzo Porta, Alessandro A. Lemos, Lucio Caccamo, Eleonora Tobaldini, Giorgio Costantino. A woman with abdominal pain, jaundice and elevated CA 19.9Internal and Emergency Medicine 2019; 14(4): 557 doi: 10.1007/s11739-018-1879-x
2
Giulia Malaguarnera, Saverio Latteri, Roberto Madeddu, Vito Emanuele Catania, Gaetano Bertino, Rosario Emanuele Perrotta, Francesco Dinotta, Michele Malaguarnera. High Carbohydrate 19-9 Antigen Serum Levels in Patients with Nonmelanoma Skin Cancer and Primary Occult CancerBiomedicines 2020; 8(8): 265 doi: 10.3390/biomedicines8080265
3
Ding-Li Xu, Yi-Qun Wu, Chang Xin, Qi-Feng Zhou, Ming-Liang Chen, Huan-Jun Yan. Simple cholangitis induces extremely and recurrently elevated serum carbohydrate antigen 19-9 levelHepatobiliary & Pancreatic Diseases International 2019; 18(3): 294 doi: 10.1016/j.hbpd.2019.03.008
4
Ross C. Smith. Biliary Tract and Gallbladder CancerMedical Radiology 2014; : 67 doi: 10.1007/978-3-642-40558-7_5
5
Rossella Indellicato, Aida Zulueta, Anna Caretti, Marco Trinchera. Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical ApplicationCancers 2020; 12(6): 1509 doi: 10.3390/cancers12061509
6
Xumin Huang, Zipeng Lu, Kai Zhang, Guangfu Wang, Baobao Cai, Pengfei Wu, Jie Yin, Yi Miao, Kuirong Jiang. Prognostic impact of the ratio of preoperative CA19-9 to liver enzyme levels in pancreatic cancer patients with jaundice (predictability of combined CA19-9/AST and CA19-9/γ-GGT for jaundiced PDAC patients)Pancreatology 2021;  doi: 10.1016/j.pan.2021.05.300
7
Richard J. Bold. RE: CA 19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Preoperative TherapyAnnals of Surgical Oncology 2013; 20(7): 2108 doi: 10.1245/s10434-012-2820-6
8
Bangbo Zhao, Qin Cheng, Hongtao Cao, Xingtong Zhou, Tianhao Li, Liangbo Dong, Weibin Wang. Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulasBMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08204-w
9
Min Seong Kim, Tae Joo Jeon, Ji Young Park, Jeongmin Choi, Won Chang Shin, Seong Eun Park, Ji-Young Seo, Young Moon Kim. Clinical Interpretation of Elevated CA 19-9 Levels in Obstructive Jaundice Following Benign and Malignant Pancreatobiliary DiseaseThe Korean Journal of Gastroenterology 2017; 70(2): 96 doi: 10.4166/kjg.2017.70.2.96
10
Amrita Sethi, Douglas A. Howell. Clinical Gastrointestinal Endoscopy2019; : 699 doi: 10.1016/B978-0-323-41509-5.00060-8
11
Giulia De Marchi, Salvatore Paiella, Claudio Luchini, Paola Capelli, Claudio Bassi, Luca Frulloni. Very high serum levels of CA 19-9 in autoimmune pancreatitis: Report of four cases and brief review of literatureJournal of Digestive Diseases 2016; 17(10): 697 doi: 10.1111/1751-2980.12403
12
Neha Lad, David A. Kooby. Distal CholangiocarcinomaSurgical Oncology Clinics of North America 2014; 23(2): 265 doi: 10.1016/j.soc.2013.11.001
13
He Cheng, Guopei Luo, Kaizhou Jin, Zhiwen Xiao, Yunzhen Qian, Yitao Gong, Xianjun Yu, Chen Liu. Predictive Values of Preoperative Markers for Resectable Pancreatic Body and Tail Cancer Determined by MDCT to Detect Occult MetastasesWorld Journal of Surgery 2021; 45(7): 2185 doi: 10.1007/s00268-021-06047-x
14
Ryuma Tokunaga, Yasuo Sakamoto, Shigeki Nakagawa, Naoya Yoshida, Hideo Baba. The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatmentSurgery Today 2017; 47(5): 636 doi: 10.1007/s00595-016-1464-8
15
Jianchun Xiao, Li Wang, Tao Hong, Binglu Li, Wei Liu, Qiang Qu, Chaoji Zheng, Xiaodong He, Dan Zhao. The Prognostic Value of the CA19-9/TBIL Ratio in Patients with Biliary Tract Cancers (BTCs): A Retrospective StudyJournal of Oncology 2021; 2021: 1 doi: 10.1155/2021/5829893
16
Ziyun Shen, Jun Zhang, Haoda Chen, Weishen Wang, Wei Xu, Xiongxiong Lu, Yiran Zhou, Shiwei Zhao, Zhiwei Xu, Xiaxing Deng, Jiancheng Wang, Yuanchi Weng, Baiyong Shen. Does Pre-operative Biliary Drainage Influence Long-Term Survival in Patients With Obstructive Jaundice With Resectable Pancreatic Head Cancer?Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.575316
17
Adrianne Tsen, Mary Barbara, Laura Rosenkranz. Dilemma of elevated CA 19-9 in biliary pathologyPancreatology 2018; 18(8): 862 doi: 10.1016/j.pan.2018.09.004
18
Fiona Hand, Kevin C. Conlon. Pancreatic cancerSurgery (Oxford) 2019; 37(6): 319 doi: 10.1016/j.mpsur.2019.03.005
19
Robert Dorrell, Swati Pawa, Yi Zhou, Neeraj Lalwani, Rishi Pawa. The Diagnostic Dilemma of Malignant Biliary StricturesDiagnostics 2020; 10(5): 337 doi: 10.3390/diagnostics10050337
20
Camila Lopes Vendrami, Joon Soo Shin, Nancy A. Hammond, Kunal Kothari, Pardeep K. Mittal, Frank H. Miller. Differentiation of focal autoimmune pancreatitis from pancreatic ductal adenocarcinomaAbdominal Radiology 2020; 45(5): 1371 doi: 10.1007/s00261-019-02210-0
21
Ali Abdul Hussein S. AL-Janabi, Ekhlas F. Tawfeeq. Interfering Effect of Black Tea Consumption on Diagnosis of Pancreatic Cancer by CA 19-9Journal of Gastrointestinal Cancer 2017; 48(2): 148 doi: 10.1007/s12029-016-9855-z
22
Xiao-Jie Wang, Jun-Li Ke, Jian-Xia Xu, Jia-Ping Zhou, Yuan-Fei Lu, Qiao-Mei Zhou, Dan Shi, Ri-Sheng Yu. Radiographic Features and Clinical Factor for Preoperative Prediction in the Bulging Duodenal Papilla With MalignancyFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.627482
23
Marco Trinchera, Adele Aronica, Fabio Dall’Olio. Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal CancersBiology 2017; 6(4): 16 doi: 10.3390/biology6010016
24
Mohamed O. Khalifa, Ossama A. Ahmed, Mohamed H.A. Fouad, Mohamed Abo El-Kassem Abo Deif, Mohamed Awad Mansour. Value of serum CA 19-9 in obstructive jaundiceEgyptian Liver Journal 2016; 6(3): 54 doi: 10.1097/01.ELX.0000515715.11964.86
25
Freddy Pereira-Graterol, Francisco Salazar-Marcano, Yajaira Venales-Barrios. Síndrome de Mirizzi que simulaba una neoplasia biliar malignaRevista Colombiana de Cirugía 2020; 35(3): 507 doi: 10.30944/20117582.730
26
Soo Young Jang, Jin Sil Kim, Seung Yon Baek, Hye Ah Lee, Jeong Kyong Lee. Proposed nomogram predicting neoplastic ampullary obstruction in patients with a suspected ampulla of Vater lesion on CTAbdominal Radiology 2021; 46(7): 3128 doi: 10.1007/s00261-021-02975-3
27
Ming-ming Xu, Amrita Sethi. Diagnosing Biliary MalignancyGastrointestinal Endoscopy Clinics of North America 2015; 25(4): 677 doi: 10.1016/j.giec.2015.06.011
28
Saverio Latteri, Vito Catania, Giulia Malaguarnera, Andrea Peri, Gaetano Bertino, Giuseppe Frazzetto, Antonio Borzì, Antonio Biondi, Rosario Perrotta, Michele Malaguarnera. Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin CancerBiomedicines 2018; 6(1): 24 doi: 10.3390/biomedicines6010024